Linagliptin use while Breastfeeding
Drugs containing Linagliptin: Tradjenta, Jentadueto
Linagliptin Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because no information is available on the use of linagliptin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Acarbose, Chlorpropamide, Glyburide, Insulin, Metformin, Tolbutamide
References
Linagliptin Identification
Substance Name
CAS Registry Number
668270-12-0
Drug Class
- Dipeptidyl-Peptidase IV Inhibitors
Administrative Information
LactMed Record Number
878
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2012-04-03
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Linagliptin use during Pregnancy
- Linagliptin Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
